Vision Quest Industries INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$5,446general payments (2019-2025)
$0.00research payments (2019-2025)
124clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Oactive Align Custom R $891 associated (2023-2025)
- Avid Ct2 Nmes/Ifc Stimulator $836 associated (2023-2025)
- Pro Estim Nmes Stimulator $488 associated (2023-2025)
- Bionicare Align Prefab R $377 associated (2023-2025)
- N/A $131 associated (2023-2025)
- Vq Orthocare $131 associated (2023-2025)
- Pro Estim $31.06 associated (2023-2025)
- Trulign Oa Kbr M/L Rgt $22.75 associated (2023-2025)
- Oactive Align Custom R Akpc, Push Button W/Susp Wrap $13.19 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Seleaina Thomas | Victorville, CA | Family | $234.81 |
| Jeffery Hawkins | Fort Worth, TX | Sports Medicine (Family Medicine) | $166.99 |
| Phillip Collier | Scottsdale, AZ | Anesthesiology | $161.77 |
| Harwinder Singh | Fresno, CA | Physical Medicine & Rehabilitation | $161.77 |
| Thomas Olaughlin | Clovis, CA | Pain Medicine (Physical Medicine & Rehabilitation) | $161.77 |
| Tha Cha | Fresno, CA | Physical Medicine & Rehabilitation | $161.77 |
| Steve Mora | Orange, CA | Orthopaedic Surgery | $154.48 |
| Steven Simmons | Fort Worth, TX | Interventional Pain Medicine | $147.81 |
| Michael Moon | San Diego, CA | Interventional Pain Medicine | $141.65 |
| Ara Dikranian | San Diego, CA | Rheumatology | $118.93 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.